CompletedNot Applicable

Radial Extracorporeal Shock Wave Therapy Versus Platelet-rich Plasma Injection for Greater Trochanteric Pain Syndrome

Turkey (Türkiye)30 participantsStarted 2020-08-01

Plain-language summary

Greater trochanteric pain syndrome (GTPS), is characterised by pain around the greater trochanter. Failure of first-line management for GTPS is followed by second-line treatments range from extracorporeal shock wave therapy (ESWT), corticosteroid or platelet-rich plasma (PRP) injections, and surgery. In a systematic reviews, PRP seems a viable effective and safe alternative option for GTPS after failed physical therapy. Also, positive results from previous systematic reviews involving radial ESWT (rESWT) as a treatment for GTPS. In the literature review, there is no comparison of the effectiveness of ESWT and PRP injection in patients with GTPS. The aim of this study was to investigate the effects of rESWT and PRP injection on pain, hip disability, and quality of life in patients with GTPS

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * \> 18 years old * Complaining of pain located anterior, lateral or posterior to the great trochanter for more than 3 months * Pain while lying on the affected side * Local tenderness on palpation of the area of the great trochanter * MRI evidence of gluteus minimus or medius tendinopathy * Refractory to conservative management Exclusion Criteria: * Presence of signs and symptoms of another cause of regional hip pain. * Full-thickness tear of the involved gluteal tendons, bursa, and intra-articular structures * Evidence of concomitant injury to the involved lower extremity, including radiculopathy or radiculitis, ischial tuberosity avulsion * Severe knee or hip osteoarthritis * Previous hip surgery or use of ESWT for GTPS. * Acute low back pain * Implanted pacemaker * Vascular, neurologic, rheumatic diseases. * Any neoplastic disorders * Blood coagulation disorders or use of antiplatelet or anticoagulant drugs * Pregnancy.

What they're measuring

Harris Hip Score (HHS)

Timeframe: Changes from baseline in Harris Hip Score to 1 month and 6 months.

Trial details

NCT IDNCT04537091

SponsorIstanbul Physical Medicine Rehabilitation Training and Research Hospital

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2020-12-01